Search results for "Dermatitis"

showing 10 items of 220 documents

The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction

1998

We have evaluated the effects of three potent immunosuppressive agents, cyclosporin A (CsA), FK506 and rapamycin, on the murine contact sensitivity (CS) reaction to the hapten trinitrochlorobenzene. Development of CS reaction requires participation of three distinct T cell subsets: alphabeta+, CD4+ T lymphocytes, which are the classical effector cell of the CS reaction, gammadelta+ T lymphocytes, and alphabeta+, double-negative (CD4- CD8-) T lymphocytes that express the B220 molecule and produce IL-4. We found that all three drugs inhibit the development of the CS reaction, but they affect different target cells. In fact, rapamycin and FK-506 block both alphabeta+, CD4+ and gammadelta+ T ly…

MaleInterleukin 2Cellular immunityReceptors Antigen T-Cell alpha-betamedicine.medical_treatmentT cellImmunologyPicryl ChloridePolyenesBiologyDermatitis ContactLymphocyte ActivationTacrolimusMiceImmune systemAntigenT-Lymphocyte SubsetsCyclosporin amedicineAnimalsImmunology and AllergySirolimusReceptors Antigen T-Cell gamma-deltaOriginal ArticlesT lymphocyteCytokinemedicine.anatomical_structureImmunologyCyclosporineMice Inbred CBAImmunosuppressive Agentsmedicine.drugClinical and Experimental Immunology
researchProduct

Contact Allergens Modulate the Expression of MHC Class II Molecules on Murine Epidermal Langerhans Cells by Endocytotic Mechanisms

1992

MHC class II molecules play an important role during the sensitization phase of allergic contact dermatitis. To study the influence of contact allergens on the expression of these molecules by murine epidermal Langerhans cells (LC), we performed a flow-cytofluorometric analysis of the Ia-antigen expression after in vivo application of contact allergens. A distinct decrease in the Ia-antigen expression of the entire LC population was noticed 3 h after in vivo application of the contact allergen 2,4-dinitrofluorobenzene (DNFB). This decrease was transient and balanced 24 h after in vivo application of DNFB. A downregulation was also detectable after in vivo application of the contact allergen…

MaleLangerhans cellHypertonic SolutionsPopulationCyclopentanesDermatologyDermatitis ContactBiochemistryOxazoloneMicechemistry.chemical_compoundIn vivomedicineAnimalsMonensineducationMolecular BiologyAllergic contact dermatitisSensitizationMice Inbred BALB CMHC class IIeducation.field_of_studyBrefeldin AbiologyChemistryHistocompatibility Antigens Class IIAntibodies MonoclonalCell BiologyAllergensmedicine.diseaseMolecular biologyEndocytosisIn vitromedicine.anatomical_structureLangerhans CellsImmunologybiology.proteinFemaleJournal of Investigative Dermatology
researchProduct

Atopic dermatitis and indoor use of energy sources in cooking and heating appliances

2012

Abstract Background Atopic dermatitis (AD) prevalence has considerably increased worldwide in recent years. Studying indoor environments is particularly relevant, especially in industrialised countries where many people spend 80% of their time at home, particularly children. This study is aimed to identify the potential association between AD and the energy source (biomass, gas and electricity) used for cooking and domestic heating in a Spanish schoolchildren population. Methods As part of the ISAAC (International Study of Asthma and Allergies in Childhood) phase III study, a cross-sectional population-based survey was conducted with 21,355 6-to-7-year-old children from 8 Spanish ISAAC cent…

MaleParentsPediatricsmedicine.medical_specialtyBioelectric Energy SourcesCross-sectional studyPopulationSocial EnvironmentLogistic regressionDermatitis AtopicHeatingElectricitySurveys and QuestionnairesEnvironmental healthOdds RatiomedicineHumansCookingBiomassIndoorParent-Child RelationsChildeducationLife StyleChildrenAtopic dermatitiseducation.field_of_studyAnthropometrybusiness.industrylcsh:Public aspects of medicineSmokingPublic Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratioAnthropometryConfidence intervalCross-Sectional StudiesSpainGasAir Pollution IndoorPopulation studyFemaleEnergy sourcebusinessResearch ArticleBMC Public Health
researchProduct

Local skin necroses after intramuscular injection -Experimental animal studies-.

1977

The pathogenesis of local skin necroses after intramuscular injection of various drugs such as phenylbutazone (Embolia cutis medicamentosa, Nicolau's syndrome) is not clear. In an attempt to simulate this clinical feature experiments were performed on the rabbit ear lobe. A 20% phenylbutazone solution was injected paraarterial, intraarterial and paraarterial after perforation of the vessel. The drug produced a violent inflammation with all kinds of application. The local inflammation induced by paraarterial injection resulted in a fine scarring. Both other kinds of application produced necroses or even perforations. The histological examinations in these cases revealed massive destructions …

MalePathologymedicine.medical_specialtyNecrosisPerforation (oil well)InflammationDermatologyDermatitis ContactInjections IntramuscularSkin DiseasesPathogenesisLesionNecrosismedicinePhenylbutazoneAnimalsSkinbusiness.industryGeneral MedicineSurgerymedicine.anatomical_structurePhenylbutazoneBlood VesselsFemaleRabbitsmedicine.symptombusinessIntramuscular injectionmedicine.drugArteryArchives for dermatological research = Archiv fur dermatologische Forschung
researchProduct

Air Pollution and Recent Symptoms of Asthma, Allergic Rhinitis, and Atopic Eczema in Schoolchildren Aged Between 6 and 7 Years

2008

Abstract Objective The objective of the study was to analyze the relationship between air pollutants and the prevalence of recent symptoms of asthma, allergic rhinitis, and atopic eczema in schoolchildren aged between 6 and 7 years. Patients and Methods The prevalence of recent (previous 12 months) symptoms of allergic diseases was obtained by means of the questionnaire of the International Study of Asthma and Allergies in Childhood (ISAAC), Spain, with the participation of 7 centers (Asturias, Barcelona, Bilbao, Cartagena, La Coruna, Madrid, and Valencia) and 20 455 schoolchildren aged between 6 and 7 years, from 2002 to 2003. The pollutant detection systems of the aforementioned centers p…

MalePediatricsmedicine.medical_specialtyAllergyRhinitis Allergic PerennialMeteorological ConceptsUrban PopulationSevere asthmaNitrogen DioxideAnnual averageAir pollutionmedicine.disease_causeDermatitis AtopicAir PollutionEnvironmental healthPrevalenceHumansSulfur DioxideMedicineChildRespiratory SoundsAsthmaAir PollutantsCarbon Monoxidebusiness.industryDry coughRhinitis Allergic SeasonalGeneral MedicineOdds ratiomedicine.diseaseAsthmaConfidence intervalCoughSpainFemaleParticulate MatterbusinessArchivos de Bronconeumología ((English Edition))
researchProduct

Sensitization in early age to food allergens in children with atopic dermatitis

2007

Background: Clinical and laboratory evidence increasingly supports the notion that food allergy plays a role in the pathogenesis of atopic dermatitis (AD). However, the prevalence of clinically significant food hypersensitivity among children with AD remains an unanswered question. Objective: To prospectively determine the prevalence of IgE-mediated food hypersensitivity among patients referred to a dermatology department for evaluation of AD, and to analyze the clinical relevance of these sensitizations in AD. Methods: We studied 44 infants of both sexes, aged less than 12 months old, who attended the dermatology department with symptoms of AD. Compliance with Hanifin-Rajka criteria was co…

MalePulmonary and Respiratory Medicinefood hypersensitivitymedicine.medical_specialtyEggsImmunologyEgg Proteins DietarySeverity of Illness IndexDermatitis Atopicfood challengeAntibody SpecificityFood allergyElimination dietPrevalencemedicineAnimalsHumansImmunology and AllergyClinical significanceProspective StudiesAge of OnsetFood allergensSensitizationSkin Testsfood allergyatopic dermatitisbusiness.industryInfantegg allergyGeneral MedicineAtopic dermatitisAllergensImmunoglobulin EMilk Proteinsmedicine.diseaseFood hypersensitivityDermatologycow's milk allergymedicine.anatomical_structureEgg allergyCattleFemaleInfant FoodMilk HypersensitivitybusinessChickensFood Hypersensitivity
researchProduct

Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial

2018

Background: The long-term efficacy of corticosteroids to prevent atopic dermatitis (AD) relapses has partially been addressed in children. This study compared an intermittent dosing regimen of fluticasone propionate (FP) cream 0.05% with its vehicle base in reducing the risk of relapse in children with stabilized AD. Methods A randomized controlled, multicentric, double-blind trial was conducted. Children (2-10 years) with mild/moderate AD (exclusion criteria: > 30% affected body surface area and/or head) were enrolled into an Open-label Stabilization Phase (OSP) of up to 2 weeks on twice daily FP. Those who achieved treatment success entered the Double-blind Maintenance Phase (DMP). They w…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyImmunologyAnti-Inflammatory AgentsLower riskFluticasone propionateIntermittent dosingFluticasone propionateDermatitis Atopiclaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallaw030225 pediatricsInternal medicineSecondary PreventionmedicineAtopic dermatitis Clinical trial Fluticasone propionate Intermittent dosing PreventionHumansImmunology and AllergyChildFluticasoneAtopic dermatitisBody surface areabusiness.industryPreventionGeneral MedicineAtopic dermatitismedicine.diseaseClinical trialRegimenChild PreschoolRelative riskFluticasoneFemalebusinessmedicine.drug
researchProduct

Chronic Urticaria After Implantation of a Mitral Annuloplasty Ring in a Nickel-Allergic Patient

2017

MaleReoperationNickel allergymedicine.medical_specialtyMitral Valve AnnuloplastyUrticariaImmunology030204 cardiovascular system & hematologyProsthesis DesignImmunoglobulin E03 medical and health sciences0302 clinical medicineMitral annuloplasty ringDevice removalNickelMitral valve annuloplastyInternal medicineHumansImmunology and AllergyMedicineProsthesis designDevice RemovalChronic urticariaHeart Valve Prosthesis Implantationbiologybusiness.industryMiddle AgedPatch TestsSurgeryChronic diseaseHeart Valve ProsthesisChronic DiseaseDermatitis Allergic ContactCardiologybiology.proteinMitral Valvebusiness030217 neurology & neurosurgeryJournal of Investigational Allergology and Clinical Immunology
researchProduct

Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis.

2011

Background Therapy of atopic dermatitis (AD) relies on immunosuppression and/or UV irradiation. Here, we assessed clinical efficacy and histopathological alterations induced by blue light-treatment of AD within an observational, non-interventional study. Methodology/Principal Findings 36 patients with severe, chronic AD resisting long term disease control with local corticosteroids were included. Treatment consisted of one cycle of 5 consecutive blue light-irradiations (28.9 J/cm2). Patients were instructed to ask for treatment upon disease exacerbation despite interval therapy with topical corticosteroids. The majority of patients noted first improvements after 2–3 cycles. The EASI score w…

MaleSkin PhysiologyAnatomy and PhysiologyLightmedicine.medical_treatmentlcsh:MedicinePediatric DermatologyAntigen Processing and RecognitionAtopic DermatitisDiseasePediatricsQuality of lifeYoung adultlcsh:ScienceSkinMultidisciplinarymedicine.diagnostic_testT CellsAllergy and HypersensitivityPhysicsElectromagnetic RadiationPhotodermatology and Skin AgingImmunosuppressionAtopic dermatitisMiddle Agedmedicine.anatomical_structureTreatment OutcomePatient SatisfactionObservational StudiesMedicineFemaleWhole-Body IrradiationResearch ArticleAdultmedicine.medical_specialtyLangerhans cellClinical Research DesignImmune CellsImmunologyColorDermatologyDermatitis AtopicYoung AdultUltraviolet RadiationBiopsymedicineHumansSerologic TestsBiologybusiness.industrylcsh:Rmedicine.diseaseDermatologyClinical trialImmune SystemChronic DiseaseQuality of Lifelcsh:QClinical ImmunologybusinessPloS one
researchProduct

Erythroderma related to the administration of 99mTc-sestamibi: The first report

2009

MaleTechnetium Tc 99m Sestamibimedicine.medical_specialtybusiness.industryMEDLINEErythroderma99mTc Sestamibimedicine.diseaseInternal medicineSettore MED/35 - Malattie Cutanee E VenereemedicineHumansRadiology Nuclear Medicine and imagingDrug EruptionsRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessAdministration (government)Dermatitis ExfoliativeAgedRadiopharmaceuticals Technetium 99m sestamibi erythroderma.Journal of Nuclear Cardiology
researchProduct